Want to join the conversation?
British pharmaceutical group $GSK said it would buy the portfolio of experimental HIV drugs from its U.S. rival $BMY for a total of $1.46Bil in two transactions. $GSK expects to complete both the transactions during the first half of FY16. The deal is expected to strengthen $GSK's global HIV business ViiV Healthcare's control in the HIV market.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.